Abound Wealth Management Dexcom Inc Transaction History
Abound Wealth Management
- $300 Billion
- Q1 2025
A detailed history of Abound Wealth Management transactions in Dexcom Inc stock. As of the latest transaction made, Abound Wealth Management holds 31 shares of DXCM stock, worth $2,056. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31
Previous 51
39.22%
Holding current value
$2,056
Previous $3.97 Million
46.63%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding DXCM
# of Institutions
1,087Shares Held
353MCall Options Held
8.45MPut Options Held
5.75M-
Vanguard Group Inc Valley Forge, PA46.5MShares$3.09 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.29 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.11 Billion0.05% of portfolio
-
Baillie Gifford & CO14.6MShares$969 Million0.9% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.4MShares$953 Million0.24% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $25.6B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...